DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Fehrenbacher L, Spira A, Ballinger M. et al.
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): A multicentre, open-label, phase 2 randomised controlled trial.
Lancet (London, England) 2016;
387: 1837-1846
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.